SCHEMBL27613083

SCHEMBL27613083

O/C=C(\F)Cc1ccc(-c2ccccn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CA12 O43570 7/20 0.41
▸ CA1 P00915 7/20 0.41
▸ CA2 P00918 7/20 0.41
▸ CA9 Q16790 7/20 0.41
▸ CA5A P35218 6/20 0.41
▸ CA5B Q9Y2D0 6/20 0.41
▸ HCAR2 Q8TDS4 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CCR1 P32246 1/20 0.39
▸ CCR5 P51681 1/20 0.39
▸ CCR8 P51685 1/20 0.39
▸ METAP1 P53582 1/20 0.39
▸ BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27594249 0.82 ADRB2 (0.50) LMNAWNT3AMEN1SLC6A2SLC6A3
SCHEMBL27612981 0.80 WNT3A (0.42) WNT3A
SCHEMBL27612894 0.80 CYP2D6 (0.43) CYP2D6CYP19A1CYP2C9WNT3A
SCHEMBL27612961 0.76 KDM4E (0.36) CYP1A2CYP19A1CA12CA1CA2
SCHEMBL27613084 0.76 KDM4E (0.40) CYP1A2CYP19A1KDM4ELMNAPOLB
SCHEMBL538208 0.76 ABCC4 (0.61) CA12CA1CA2CA9CA5A
SCHEMBL30433544 0.76 ABCC4 (0.61) CA12CA1CA2CA9CA5A
SCHEMBL27612999 0.75 CYP17A1 (0.42) CYP19A1LMNAWNT3A
SCHEMBL533591 0.74 KDM4E (0.50) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL676001 0.74 KDM4E (0.50) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1585775-A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials ORTHO MCNEIL PHARM INC (US) 2005-02-23 — — CN disclosed
Send feedback